TLRY Earnings Date: Jan 11, 2027 (Estimated) — Tilray Brands, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Updated
When is TLRY's next earnings date?
Tilray Brands, Inc. (TLRY) is expected to report Q2 2027 earnings on Monday, January 11, 2027 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.01 on revenue of $272.2M.
How did TLRY do in its last earnings report?
In its most recent report on Oct 8, 2026 (Q1 2027), Tilray Brands, Inc. posted EPS of -$0.32 versus the -$0.17 estimate, a miss of 90.5%. Revenue was $257.1M against a $268.7M estimate. The stock's 1-day post-earnings move was -3.4%.
How much does TLRY stock move after earnings?
TLRY beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 10.1% (up or down) in the day after earnings.
About Tilray Brands, Inc.
Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-08 | Q1 2027 | -0.17 | -0.32 | -90.48% | $257.1M | ❌ Miss | -3.36% | -15.48% | — |
| 2026-07-28 | Q4 2026 | 0.21 | 0.05 | -76.19% | $281.7M | ❌ Miss | -0.99% | +15.14% | +15.14% |
| 2026-04-01 | Q3 2026 | -0.01 | 0.02 | +300.00% | $206.7M | ✅ Beat | -5.10% | +4.33% | -3.55% |
| 2026-01-08 | Q2 2026 | -0.06 | 0.01 | +116.67% | $217.5M | ✅ Beat | +0.55% | +6.35% | -15.66% |
| 2025-10-09 | Q1 2026 | -0.01 | 0.00 | +100.00% | $209.5M | ✅ Beat | +22.09% | -2.33% | -29.65% |
| 2025-07-28 | Q4 2025 | -0.01 | 0.02 | +300.00% | $224.5M | ✅ Beat | -17.55% | -13.13% | +107.23% |
| 2025-04-08 | Q3 2025 | -0.03 | 0.00 | +100.00% | $185.8M | ✅ Beat | -21.23% | -15.97% | -25.38% |
| 2025-01-10 | Q2 2025 | -0.01 | 0.00 | +100.00% | $210.9M | ✅ Beat | -10.22% | -13.87% | -28.43% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q1 FY27 · $279.0M total
| Segment | Share | Revenue | YoY | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|
| Beverage Alcohol Business | 37.4% | $104.2M | +78.1% | $58.0M | $69.1M | $58.5M | $53.6M |
| Distribution Revenue | 30.2% | $84.3M | +13.9% | $61.5M | $74.1M | $74.0M | $85.3M |
| Cannabis | 27.0% | $75.2M | -14.3% | $73.0M | $89.2M | $87.7M | $90.2M |
| Wellness Business | 5.5% | $15.3M | +0.2% | $14.1M | $17.0M | $15.2M | $14.6M |
By region
Q1 FY27 · $257.1M total
| Segment | Share | Revenue | YoY | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|
| EMEA | 56.6% | $145.5M | +70.7% | $72.4M | $94.0M | $85.3M | $103.2M |
| UNITED STATES | 22.7% | $58.3M | -8.8% | $64.4M | $73.6M | $64.0M | $57.8M |
| CANADA | 18.8% | $48.4M | -16.7% | $45.9M | $54.3M | $58.2M | $54.2M |
| Rest of World | 1.9% | $4.9M | +129.6% | $3.0M | $2.5M | $2.1M | $2.3M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.